Teal Health Targets OB/GYN Engagement at Major ACOG 2026 Conference

According to a recent LinkedIn post from Teal Health, the company plans to exhibit at the American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting (ACOG ACSM) in Washington, D.C., scheduled for May 1–3, 2026. The event is described in the post as the country’s largest gathering of OB/GYNs and marks ACOG’s 75th anniversary.

The company’s LinkedIn post highlights its intent to engage with clinicians and researchers focused on women’s health and to discuss ways to expand access to cervical cancer screening. The post also notes that Teal Health’s Medical Director, Liz Swenson, along with team members Trena Depel and Alexandra Ripkin, is expected to be present at Booth No. 1243 during the meeting.

For investors, the planned presence at ACOG ACSM suggests an effort to deepen relationships with key medical decision-makers and influencers in obstetrics and gynecology. Increased visibility in this specialized clinical community could support future adoption of Teal Health’s solutions, potentially affecting long-term revenue opportunities if the company’s offerings align with unmet needs in cervical cancer screening.

The focus on cervical cancer screening access in the post underscores a positioning in preventive women’s health, a segment that may benefit from growing awareness and policy support around early detection. Participation in a major professional conference also indicates ongoing commercial and clinical outreach activities, which may be relevant for assessing Teal Health’s go-to-market execution and competitive standing within the women’s health diagnostics landscape.